Aura Biosciences Inc (AURA) Straddle

Trading a AURA straddle lets you take a pure volatility position on Aura Biosciences Inc without committing to a direction. Aura Biosciences Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate AURA straddle pricing in real time and find the moments when expected moves are mispriced.

A long straddle on AURA profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Aura Biosciences Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the AURA straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.

Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develops AU-011 in additional ocular oncology indications, including choroidal metastases. The company was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.

Earnings, product cycles, macro prints — any time volatility itself is the trade, the AURA straddle is the cleanest expression of that view. Our scanner prices every AURA straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a AURA straddle into a catalyst or short a AURA straddle to harvest decay, the options straddle setups that matter are all in one place.